MODERNA INC revenue for the last year amounted to 2.94 B CHF, the most of which — 2.94 B CHF — came from its highest performing source at the moment, Messenger RNA (mRNA) Medicines, the year earlier bringing 5.77 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought MODERNA INC 1.62 B CHF, and the year before that — 1.60 B CHF.